MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-20-0041377
Halsted Pharma Private Limited - pharma in Hyderabad, Telangana, India. Directors, charges & compliance details.
Revenue · FY 2025
₹36.78 Cr
▼ 7% YoY
Net loss · FY 2025
₹5.73 Cr
Net margin -15.6%
EBITDA · FY 2025
-₹5.03 Cr
EBITDA margin -13.7%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹24.76 Cr
Issued & subscribed
Open charges
₹8 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Employees · EPFO
85
Provident fund records
About Halsted Pharma Private Limited
Data last updated:
Halsted Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 September 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2022PTC166288.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹24.76 Cr. It is led by directors including Harsh Kumar Saxena (Whole-Time Director) and Nagesh Kumar Middey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor Plot No.25 – Hig Phase Xv Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.78 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹5.73 Cr (net margin -15.6%) and EBITDA of -₹5.03 Cr (EBITDA margin -13.7%).
The company has about 85 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Halsted Pharma. As per MCA filings, the company has open charges of ₹8 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 3 cases are pending.
Halsted Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-20-0041377). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website halstedpharma.com.
Company details
CIN U24290TG2022PTC166288
Registration Number 166288
Incorporation Date 02 September 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-20-0041377
Key People
Harsh Kumar Saxena Whole-Time Director Nagesh Kumar Middey Director Raghuveer Adusumilli Director Recognitions & Rankings of Halsted Pharma
Contact details
Halsted Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressGround Floor Plot No.25 – Hig Phase Xv Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Halsted Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Halsted Pharma operates one associated brand: Halsted Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures therapies for oncology, haematology, and neurology through reverse engineering. | halstedpharma.com |
Business activity
The main business activity of Halsted Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Halsted Pharma Private Limited, buy the company report.
Financials of Halsted Pharma Private Limited
FY 2025 filings availableHalsted Pharma Private Limited reported revenue of ₹36.78 Cr (down 7% YoY) for FY 2025.
Revenue · FY 2025
₹36.78 Cr ▼ 7%
Net loss · FY 2025
₹5.73 Cr margin -15.6%
EBITDA · FY 2025
-₹5.03 Cr margin -13.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
EBITDA CAGR growth
1 year
▼ 3%
Revenue fell 7% in the latest year. EBITDA fell 3% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹5.03 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹5.73 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -13.7% | ||
| Net Profit Margin | -15.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Halsted Pharma Private Limited, buy the company report.
Board of directors of Halsted Pharma Private Limited
Halsted Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagesh Kumar Middey Also directs: Vivint Healthcare Private Limited, Vivint Laboratories Private Limited, Questus Pharma Private Limited and 3 more | Director | 09 Oct 2023 | 3 Years 0 Months | Current |
| Raghuveer Adusumilli Also directs: Vivint Healthcare Private Limited, Vivint Laboratories Private Limited, Questus Pharma Private Limited and 3 more | Director | 28 Sep 2022 | 4 Years 0 Months | Current |
| Harsh Kumar Saxena | Whole-Time Director | 17 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Halsted Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sarveshwar Metals Private Limited | ₹36.8 Cr (FY 2025) | 7.0% | Ahmedabad, Gujarat, India | |||
| Gandhar Silk Mills Private Limited | ₹36.79 Cr (FY 2025) | -5.0% | Surat, Gujarat, India | |||
| Highrise International Private Limited | ₹36.79 Cr (FY 2025) | 140.0% | Delhi, India | |||
| Purti Contract Farming Private Limited | ₹36.79 Cr (FY 2024) | 1248.0% | Nagpur, Maharashtra, India | |||
| Genpharmasec Limited | ₹36.78 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Halsted Pharma Private Limitedthis company | ₹36.78 Cr (FY 2025) | -₹5.73 Cr | -15.6% | -7.0% | Hyderabad, Telangana, India | |
| Sabita Auto Agency Private Limited | ₹36.77 Cr (FY 2024) | 47.0% | Samastipur, Bihar, India | |||
| SJ Worldtrade Private Limited | ₹36.77 Cr (FY 2024) | -38.0% | Kolkata, West Bengal, India | |||
| Radha Krishna Impex Private Limited | ₹36.76 Cr (FY 2025) | -33.0% | Muzaffarpur, Bihar, India | |||
| Conspark Developers and Farms Private Limited | ₹36.76 Cr (FY 2025) | -33.0% | Mumbai, Maharashtra, India | |||
| Svojas Milk & Milk Products Private Limited | ₹36.76 Cr (FY 2025) | 383.0% | Pandharpur, Maharashtra, India |
To see the full peer comparison of Halsted Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Dec 2023 | 100838219 | Hdfc Bank Limited | ₹8 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Halsted Pharma Private Limited has 7 court cases on record: 2 filed by Halsted Pharma, 5 filed against it. 3 cases are pending and 4 are disposed.
Total cases
7
Filed by the company
2
Filed against the company
5
Pending
3
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 4 | 0 |
| District courts | 3 | 1 | 3 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Cosmas Research Lab Ltd. | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Axiommax Oncology Private Limited | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by Axiommax Oncology Private Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Axiommax Oncology Private Limited | Disposed |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Axiommax Oncology Private Limited | Disposed |
To see the full case history of Halsted Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Halsted Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Halsted Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Halsted Pharma Private Limited has 9 board changes on record since 2022: 3 appointments and 6 cessations. The latest: Nagesh Kumar Middey ceased to be Additional Director on 12 Dec 2023.
AGM
Halsted Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Halsted Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Nagesh Kumar Middey ceased to be Additional Director.
Ceased
Raghuveer Adusumilli ceased to be Additional Director.
Ceased
Venkata Ramaiah Jagarlamudi ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.00 Cr with Charge ID 100838219 was registered on 07 Dec 2023.
Appointed
Nagesh Kumar Middey was appointed as Director.
Appointed
Harsh Kumar Saxena was appointed as Whole-Time Director.
Ceased
Harsh Kumar Saxena ceased to be Additional Director.
Ceased
Priti Tejaswee ceased to be Director.
Ceased
Shashi Kant ceased to be Director.
Appointed
Raghuveer Adusumilli was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Halsted Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 September 2022 (4+ years old) and is registered under CIN U24290TG2022PTC166288.
Halsted Pharma has 3 current directors:
- Harsh Kumar Saxena - Whole-Time Director
- Nagesh Kumar Middey - Director
- Raghuveer Adusumilli - Director
The latest financial statements of Halsted Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Halsted Pharma is U24290TG2022PTC166288. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Halsted Pharma has 7 court cases on record: 2 filed by the company and 5 filed against it. 3 are pending. Most are in the high courts.
Halsted Pharma was incorporated on 02 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Halsted Pharma by revenue are Sarveshwar Metals Private Limited, Gandhar Silk Mills Private Limited, Highrise International Private Limited, Purti Contract Farming Private Limited, Genpharmasec Limited and 5 more, all in the same principal business activity (wholesale trading).
Nagesh Kumar Middey ceased to be Additional Director on 12 Dec 2023. Raghuveer Adusumilli ceased to be Additional Director on 12 Dec 2023. Venkata Ramaiah Jagarlamudi ceased to be Additional Director on 12 Dec 2023. Halsted Pharma has 9 board changes on record in total.
Yes, Halsted Pharma is registered as an MSME under Udyam registration (number: UDYAM-TS-20-0041377).
Halsted Pharma can be reached through the website halstedpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Halsted Pharma is at Ground Floor Plot No.25 – Hig Phase Xv Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500072.